321 results on '"Tham, Wai-Hong"'
Search Results
52. Decision letter: Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
53. Basis for drug selectivity of plasmepsin IX and X inhibition for Plasmodium falciparum and vivax
54. Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain
55. A Novel Family of Apicomplexan Glideosome-associated Proteins with an Inner Membrane-anchoring Role
56. More than just immune evasion: Hijacking complement by Plasmodium falciparum
57. MALARIA: A master lock for deadly parasites
58. Heterologous SARS‐CoV‐2 IgA neutralising antibody responses in convalescent plasma.
59. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay
60. Application of 23 Novel Serological Markers for Identifying Recent Exposure to Plasmodium vivax Parasites in an Endemic Population of Western Thailand
61. IgG Antibody Responses Are Preferential Compared With IgM for Use as Serological Markers for Detecting Recent Exposure to Plasmodium vivax Infection
62. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 RBD variants with a novel competitive multiplex assay
63. Naturally acquired blocking human monoclonal antibodies to Plasmodium vivax reticulocyte binding protein 2b
64. Identification of basic transcriptional elements required for rif gene transcription
65. Transcription and coregulation of multigene families in Plasmodium falciparum
66. Nanobody generation and structural characterization of Plasmodium falciparum 6-cysteine protein Pf12p
67. Surface Area-to-Volume Ratio, not Cellular Viscoelasticity is the Major Determinant of Red Blood Cell Traversal through Small Channels
68. Basis for Drug Selectivity of Plasmepsin IX and X Inhibition for Plasmodium falciparum and vivax
69. The FK506 protein Fp3 counteracts protein phosphatase 1 to maintain meiotic recombination checkpoint activity
70. The FK506 Binding Protein Fpr3 Counteracts Protein Phosphatase 1 to Maintain Meiotic Recombination Checkpoint Activity
71. Nanobody generation and structural characterization of Plasmodium falciparum 6-cysteine protein Pf12p
72. A comparison of non-magnetic and magnetic beads for measuring IgG antibodies against Plasmodium vivax antigens in a multiplexed bead-based assay using Luminex technology (Bio-Plex 200 or MAGPIX)
73. Transcriptional silencing at Saccharomyces telomeres: implications for other organisms
74. Surface area‐to‐volume ratio, not cellular viscoelasticity, is the major determinant of red blood cell traversal through small channels
75. IgG antibody responses are preferential compared to IgM for use as serological markers for detecting recent exposure to Plasmodium vivax infection
76. Decision letter: Structural ordering of the Plasmodium berghei circumsporozoite protein repeats by inhibitory antibody 3D11
77. Surface area-to-volume ratio, not cellular rigidity, determines red blood cell traversal through small capillaries
78. Immunogenic profile of SARS-CoV-2 spike in individuals recovered from COVID-19
79. Naturally acquired blocking human monoclonal antibodies to Plasmodium vivax reticulocyte binding protein 2b
80. Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle
81. A master lock for deadly parasites
82. Alveolins, a New Family of Cortical Proteins that Define the Protist Infrakingdom Alveolata
83. Cell biology: Telomeric tethers
84. Complement in malaria immunity and vaccines
85. Plasmodium vivax Reticulocyte Binding Proteins for invasion into reticulocytes
86. Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against P. vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand
87. Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes
88. Evaluation of 4-Amino 2-Anilinoquinazolines against Plasmodium and Other Apicomplexan Parasites In Vitro and in a P. falciparum Humanized NOD- scid IL2Rγ null Mouse Model of Malaria
89. Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria
90. Structure of Plasmodium falciparum Rh5–CyRPA–Ripr invasion complex
91. Surface area‐to‐volume ratio, not cellular viscoelasticity, is the major determinant of red blood cell traversal through small channels.
92. Complement in malaria immunity and vaccines.
93. Development and validation of serological markers for detecting recent exposure toPlasmodium vivaxinfection
94. Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development
95. Author response: Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development
96. The Molecular Basis of Erythrocyte Invasion by Malaria Parasites
97. Recruitment of Human C1 Esterase Inhibitor Controls Complement Activation on Blood Stage Plasmodium falciparum Merozoites
98. Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand
99. Plasmodium falciparum ligand binding to erythrocytes induce alterations in deformability essential for invasion
100. Editorial: Molecular Approaches to Malaria, 2016
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.